The U.S. Food and Drug Administration (FDA) on Friday cleared Dexcom Inc.‘s DXCM Stelo Glucose Biosensor System for ...
Dexcom has received Food and Drug Administration clearance for the first over-the-counter glucose sensor for children. The ...
The FDA’s indication expansion for Dexcom’s Stelo makes it the first over the counter CGM available for children, including those with diabetes.
The Food and Drug Administration (FDA) approved the first over-the-counter continuous glucose monitor for children under 18.
Compare Apple Watch CGM apps for blood sugar readings, including Dexcom G7, FreeStyle Libre, and Eversense watch support.
DexCom (NasdaqGS:DXCM) reported new clinical data from its CONNECT trial on the Dexcom G7 continuous glucose monitoring system in adults with Type 2 diabetes not using insulin. The company introduced ...
By Sneha S K June 6 (Reuters) - Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to ...
Through independent moderation by Vital Findings, council members reinforced that Dexcom remains a life-changing, essential ...
Customers have known for months that the Dexcom G7 continuous glucose monitoring sensor had problems. Now, the company is ...
MyLife Diabetes Care, CamDiab and Dexcom today announced the integration of the G7 continuous glucose monitor (CGM) into the ...
June 11 (Reuters) - Drug wholesaler Pharmsource LLC said it was unaware the Dexcom glucose sensors it bought from licensed ...
DXCM banks on CGM market growth, expanding international demand and strong Q1 momentum, though competitive pressures remain a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results